Metformin alters therapeutic effects in the BALB/c tumor therapy model

BACKGROUND: Despite considerable medical proceedings, cancer is still a leading cause of death. Major problems for tumor therapy are chemoresistance as well as toxic side effects. In recent years, the additional treatment with the antidiabetic drug metformin during chemotherapy showed promising resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Felix B., Goebel, Sophie, Spangel, Sonja B., Leovsky, Christiane, Hoelzer, Doerte, Thierbach, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161985/
https://www.ncbi.nlm.nih.gov/pubmed/34044797
http://dx.doi.org/10.1186/s12885-021-08354-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161985/
https://www.ncbi.nlm.nih.gov/pubmed/34044797
http://dx.doi.org/10.1186/s12885-021-08354-x

Ejemplares similares